@FierceMedDev: ICYMI: Two new med tech incubators in the works--one with the AMA, the other Georgia Tech. Article | Follow @FierceMedDev
@VarunSaxena2: $PFE exec says $HSP device biz "differentiates them from the competition," giving PFE "new capabilities" & a "new source of revenue growth." | Follow @VarunSaxena2
@EmilyWFierce: Judge overseeing transvaginal mesh cases set to "kick it into high gear" and push for a global settlement More from Reuters | Follow @EmilyWFierce
> Radiopharmaceutical diagnostics and therapeutics player Advanced Accelerator Applications has postponed an IPO in which it planned to raise $75 million. More
> Fast Company examines what makes uber-successful tech accelerator Y Combinator tick, including an examination of its approach to development for prosthetics and medical devices. Story
> FDA has issued draft guidance on PMAs for minimally invasive glaucoma surgical devices. Guidance
> The Atlantic takes a personal look at one person's experiences using hearing aids and uses it as a lens to examine larger lessons for wearables. Story
Biotech News
@FierceBiotech: $PFE's still a likely buyer after its $17B 'hors d'oeuvre.' News | Follow @FierceBiotech
@JohnCFierce: LONDON -- Neil Woodford readies a $300M wager on struggling U.K. Article | Follow @JohnCFierce
@DamianFierce: Amazing $SNY got Tim and Eric to produce this intentionally awkward earnings video. Video | Follow @DamianFierce
> U.S. Chamber knocks IP laggards India, Indonesia, Thailand and Vietnam in Asia. News
> Activists come for the foundering Aegerion as Denner takes a stake. Article
> Synta cuts another 20% of staff and rallies around its cancer drug. More
Pharma News
@FiercePharma: Arkansas settles claims it withheld Vertex's Kalydeco on price. More | Follow @FiercePharma
@EricPFierce: UK's #MHRA closes plant making potentially contaminated globulin component macrophage activating factor. FiercePharmaManufacturing story | Follow @EricPFierce
@CarlyHFierce: Every time I read "lumacaftor," I think of this guy, Lumière. $VRTX #Friday. Picture | Follow @CarlyHFierce
> Merck KGaA expands diabetes presence in Middle East with new education program. More
> India's Cipla presses court to not honor Novartis Onbrez patent citing Lupin license deal. News
> Hospira may just be the tip of the iceberg for deal-hungry Pfizer. News